JOP20180071B1 - استخدام مشتقات أمينو ألكيل بنزوثيازبين - Google Patents

استخدام مشتقات أمينو ألكيل بنزوثيازبين

Info

Publication number
JOP20180071B1
JOP20180071B1 JOP/2018/0071A JOP20180071A JOP20180071B1 JO P20180071 B1 JOP20180071 B1 JO P20180071B1 JO P20180071 A JOP20180071 A JO P20180071A JO P20180071 B1 JOP20180071 B1 JO P20180071B1
Authority
JO
Jordan
Prior art keywords
aminoalkylbenzothiazepine
derivatives
aminoalkylbenzothiazepine derivatives
dyslipidemia
preventing
Prior art date
Application number
JOP/2018/0071A
Other languages
English (en)
Inventor
Hyungjin Jun
So Young Ki
keunho Lee
Jin Woo Jung
Dong Hyun Kim
Chi Hye Park
Hyoung Rok Bak
Original Assignee
Hk Inno N Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hk Inno N Corp filed Critical Hk Inno N Corp
Publication of JOP20180071A1 publication Critical patent/JOP20180071A1/ar
Application granted granted Critical
Publication of JOP20180071B1 publication Critical patent/JOP20180071B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

يتعلق الكشف الحالي بتركيبة صيدلانية للوقاية من أو علاج مرض الكبد الدهني غير الكحولي أو اضطراب شحوم الدم تشتمل على مشتق أمينو ألكيل بنزوثيازبين أو ملح مقبول صيدلانياً منه كمكون نشط.
JOP/2018/0071A 2017-07-21 2018-07-22 استخدام مشتقات أمينو ألكيل بنزوثيازبين JOP20180071B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170092852A KR101844184B1 (ko) 2017-07-21 2017-07-21 아미노알킬벤조티아제핀 유도체의 용도

Publications (2)

Publication Number Publication Date
JOP20180071A1 JOP20180071A1 (ar) 2019-01-21
JOP20180071B1 true JOP20180071B1 (ar) 2023-09-17

Family

ID=61976164

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2018/0071A JOP20180071B1 (ar) 2017-07-21 2018-07-22 استخدام مشتقات أمينو ألكيل بنزوثيازبين

Country Status (11)

Country Link
US (1) US11202783B2 (ar)
EP (1) EP3654987B1 (ar)
JP (1) JP6946477B2 (ar)
KR (1) KR101844184B1 (ar)
CN (1) CN110785173B (ar)
AR (1) AR112283A1 (ar)
AU (1) AU2018303109B2 (ar)
CA (1) CA3067482C (ar)
JO (1) JOP20180071B1 (ar)
TW (2) TWI752251B (ar)
WO (1) WO2019017724A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101844184B1 (ko) 2017-07-21 2018-04-02 씨제이헬스케어 주식회사 아미노알킬벤조티아제핀 유도체의 용도
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423172D0 (en) 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines
SE0000772D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab Chemical compounds
EP1749539A2 (en) * 2000-08-01 2007-02-07 Shionogi Co., Ltd. Preventives or remedies for fatty liver
GB0121337D0 (en) * 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0216321D0 (en) * 2002-07-13 2002-08-21 Astrazeneca Ab Therapeutic treatment
GB0304194D0 (en) * 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
SI2637668T1 (sl) * 2010-11-08 2016-11-30 Albiero Ab IBAT inhibitorji za zdravljenje jetrnih bolezni
JP2012224590A (ja) * 2011-04-21 2012-11-15 Shuichi Kihata コレステロール低下剤−胆汁酸腸管吸収抑制物質
KR20150088038A (ko) * 2014-01-23 2015-07-31 동국대학교 산학협력단 아미드 유도체 화합물 및 이의 용도
KR101498218B1 (ko) * 2014-09-23 2015-03-12 연세대학교 산학협력단 신규한 펜타디에노일 피페리딘 유도체 및 그의 용도
KR101674806B1 (ko) * 2014-10-20 2016-11-10 씨제이헬스케어 주식회사 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
EP3012252A1 (en) * 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
KR101844184B1 (ko) * 2017-07-21 2018-04-02 씨제이헬스케어 주식회사 아미노알킬벤조티아제핀 유도체의 용도

Also Published As

Publication number Publication date
JP6946477B2 (ja) 2021-10-06
TWI784232B (zh) 2022-11-21
EP3654987B1 (en) 2022-08-31
JP2020525464A (ja) 2020-08-27
JOP20180071A1 (ar) 2019-01-21
CA3067482C (en) 2023-03-14
TWI752251B (zh) 2022-01-11
AU2018303109A1 (en) 2019-12-19
US11202783B2 (en) 2021-12-21
EP3654987A4 (en) 2021-04-28
US20200147101A1 (en) 2020-05-14
WO2019017724A1 (en) 2019-01-24
AU2018303109B2 (en) 2021-08-12
AR112283A1 (es) 2019-10-09
CN110785173A (zh) 2020-02-11
KR101844184B1 (ko) 2018-04-02
EP3654987A1 (en) 2020-05-27
TW202019891A (zh) 2020-06-01
CA3067482A1 (en) 2019-01-24
CN110785173B (zh) 2023-01-10
TW201908298A (zh) 2019-03-01

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
EA033689B9 (ru) Ингибиторы g12c kras
WO2015200481A8 (en) Mnk inhibitors and methods related thereto
MX2019003143A (es) Compuesto heterociclico sustituido con alquinilo, su metodo de preparacion y su uso medico.
EA201692542A1 (ru) Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы
MX2017012295A (es) Derivados formilados n-heterociclicos como inhibidores de fgfr4.
EP3613419A4 (en) PHARMACEUTICAL COMPOSITION WITH INDIRUBY DERIVATIVE AS THE ACTIVE SUBSTANCE
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
TN2016000491A1 (en) Carboxamide derivatives.
PH12016501519B1 (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2019006612A (es) Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta).
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
JOP20180071B1 (ar) استخدام مشتقات أمينو ألكيل بنزوثيازبين
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
PH12020550763A1 (en) Pyridinone derivatives and their use as selective alk-2 inhibitors
MX2021007032A (es) Derivados activos de éster de testosterona, composiciones y usos de los mismos.
MX2017013103A (es) Metodos para el tratamiento de trastornos cardiovasculares.
EP3818980A4 (en) PHARMACEUTICAL COMPOSITION WITH INDIRUBIN DERIVATE AS THE ACTIVE SUBSTANCE
EA201891136A1 (ru) Фармацевтическая композиция, содержащая в качестве активного ингредиента производное 7-азаиндолин-2-она или его фармацевтически приемлемую соль
HK1251988A1 (zh) 包含作為活性成分的色甘酸或其藥學上可接受的鹽的用於預防和治療肝臟疾病的藥物組合物